Marc Dechamps

Eigen vermogen: € 18,89M; Rechtstreeks: € 15,38M
Winst: € -3,53M; Rechtstreeks: € 5,64M
Bedrijven: 37; Rechtstreeks: 4
Werknemers: 19; Rechtstreeks: 0

Deze cijfers zijn de som van de gekoppelde vennootschappen en geven niet het persoonlijke vermogen of inkomen van deze persoon weer.

Vennootschappen 4

Bedrijf	Gezondheid	Eigen vermogen	Omzet	Werknemers	Nettowinst	Totaal activa
Xmf 0659.744.114 · Director · sinds juli 2016	2.7	€ 19K	-	-	€ 135K	€ 210K
Biogencell Europe Sa 0678.674.356 · Director	2.6	€ 61K	-	-	€ -9K	€ 387K
Orsa Tech 0882.104.835 · Chairman of the board of directors · sinds oktober 2021	4.93	€ 12,95M	-	-	€ 3,00M	€ 38,69M
Investsud Innovation 1010.817.994 · Director · sinds juni 2024 · mandaat tot juni 2029	3.8	€ 2,35M	-	-	€ 37K	€ 2,36M

Bedrijfsstructuur

Mandaten en deelnemingen

X XMF 0659.744.114

B BIOXODES 0825.151.779

BE BioGenCell Europe SA 0678.674.356

OT ORSA TECH 0882.104.835

NOVADIP BIOSCIENCES 0535.575.602

0,94%

B BIOWIN 0882.768.591

SM SYNERGIA MEDICAL 0540.563.776

11,33%

W Wishbone 0543.516.635

3,24%

B BIO-SOURCING 0554.840.790

2,56%

PL PDC line Pharma 0657.842.221

2,75%

Newton Biocapital I, pricaf privée de droit belge 0674.831.275

2,64%

SM SYNERGIA MEDICAL 0540.563.776

14,67%

ET EPICS THERAPEUTICS 0690.759.071

22,87%

SM Sequana Medical 0707.821.866

3,89%

D DeuterOncology 0754.971.388

72,2%

NB NEUVASQ BIOTECHNOLOGIES 0762.966.663

16,82%

AH Aboleris Holdco 0803.217.012

31,14%

D Dim3 0862.997.221

34,4%

AT ATB THERAPEUTICS 0677.980.015

24,14%

ET EPICS THERAPEUTICS 0690.759.071

4,38%

C CURVO 0733.642.969

6,24%

R RUMEXPERTS 0742.532.822

7,1%

A AGRICELLS 0742.991.393

11,17%

VI Vives Inter-University Fund 0750.788.908

0,53%

S SPINOVIT 0780.784.375

S Sunrise 0632.607.373

8,81%

AT ATB THERAPEUTICS 0677.980.015

4,97%

V VOCSens 0721.610.714

12,1%

EB ExeVir Bio 0750.495.334

4,47%

NT NeGIO Therapeutics 0799.822.012

12,55%

S Stellaris 0804.341.222

20,02%

B BiocSol 1003.683.546

21,76%

D DeuterOncology 0754.971.388

7,85%

OO OCTIMET Oncology 0651.853.757

100%

NB NEUVASQ BIOTECHNOLOGIES 0762.966.663

0,56%

NB Newton Biocapital II 0779.335.513

3,96%

ST Santero Therapeutics 0765.790.155

8,56%

AT AUGUSTINE THERAPEUTICS 0722.705.230

3,32%

C Cellaïon 0764.522.425

16,19%

NT NeGIO Therapeutics 0799.822.012

1,79%

AH Aboleris Holdco 0803.217.012

1,14%

S Stellaris 0804.341.222

3,89%

O OPAL-SYSTEMS 0821.605.044

14,2%

B BIOXODES 0825.151.779

12,7%

IM ISTAR MEDICAL 0828.058.712

2,34%

II INVESTSUD INNOVATION 1010.817.994

AT ATB THERAPEUTICS 0677.980.015

0,9%